HeartCore Reports Strong First Quarter 2023 Financial Results


-Company’s Q1 2023 Revenue Nearly Exceeds its Full Year 2022 Revenue
-Company’s Q1 2023 Net Income Exceeds its Full Year 2022 Net Income

NEW YORK and TOKYO, May 22, 2023 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or “the Company”), a leading software development company offering Customer Experience Management Platform (“CXM Platform”) and Digital Transformation (“DX”), reported financial results for the first quarter ended March 31, 2023.

First Quarter 2023 and Recent Operational Highlights

  • Grew total number of global enterprise customers to 916 as of March 31, 2023.
  • Signed tenth Go IPO consulting service agreement with rYojbaba Inc.
  • Integrated ChatGPT, a natural language artificial intelligence model, with HeartCore CMS to support automatic content creation for websites.
  • Partnered with Works Applications and AIM Consulting to improve their respective digital auditing solutions through its DX suite of offerings.
  • Signed eighth and ninth Go IPO clients by engaging Libera Gaming Operations and ICheck Co.
  • Acquired a 51% majority stake in Sigmaways Inc., a software engineering service provider delivering IT solutions.
  • Announced that HeartCore’s Content Management System (“CMS”) was introduced by Subaru Group to its centralized management platform for approximately 100 Subaru websites.

Management Commentary
“The first quarter was impressive in several ways, namely behind our record revenue and net income figures,” said CEO Sumitaka Yamamoto. “Our core software division drove robust operating results stemming from newly adopted marketing techniques and customer acquisition methods that were implemented last year; these changes led to profitability within this sector of our company. We are seeing this encouraging trend continue to persist which is why we are confident our software division will have a strong 2023. Additionally, our recently acquired subsidiary, Sigmaways, has been seamlessly integrated within our core operations and we’ve begun to manifest the synergies and capitalize on all joint projects.

“A significant contributing factor to our record-breaking quarter relates to our Go IPO business. Following the completion of two IPOs this past quarter, we’ve been able to reap the benefits from the warrants we received as part of the deal consummation. As I’ve previously shared, we have just scratched the tip of the iceberg with our Go IPO business line, as we expect to benefit from the closing of another six deals for the remainder of this year, including our biggest one yet around SBC Medical Group, which will add approximately $32.4 million to our top line. With our two-pronged growth strategy going into full effect, I am very confident in our team’s ability to make 2023 the strongest year for HeartCore across several measures.”

First Quarter 2023 Financial Results
Revenues increased 284% to $8.7 million compared to $2.3 million in the same period last year. The increase was primarily due to the expansion of the Go IPO business, as a growing number of Japanese venture companies continue to express interest in going public on the Nasdaq, in addition to the acquisition of Sigmaways and its subsidiaries.

Gross profit increased 361% to $5.6 million (gross margin of 64%) from $1.2 million (gross margin of 54%) in the same period last year. The increase was primarily due to the aforementioned expansion of the Company’s Go IPO business.

Operating expenses increased to $3.3 million from $2.8 million in the same period last year. The increase was primarily due to increased selling expenses, as well as increased general and administrative expenses.

Net income was $1.8 million, or $0.10 per diluted share, compared to net loss of approximately $1.6 million or $(0.09) per diluted share last year. The increase in net income was primarily due to the aforementioned expansion of the Company’s Go IPO business in addition to relatively stable operating expenses.

As of March 31, 2023, the Company had cash and cash equivalents of $5.2 million compared to $7.2 million as of December 31, 2022.

About HeartCore Enterprises, Inc.
Headquartered in Tokyo, Japan, HeartCore Enterprises is a leading software development company offering Software as a Service (SaaS) solutions to enterprise customers in Japan and worldwide. The Company also provides data analytics services that allow enterprise businesses to create tailored web experiences for their clients through best-in-class design. HeartCore’s customer experience management platform (CXM Platform) includes marketing, sales, service and content management systems, as well as other tools and integrations, which enable companies to enhance the customer experience and drive engagement. HeartCore also operates a digital transformation business that provides customers with robotics process automation, process mining and task mining to accelerate the digital transformation of enterprises. Furthermore, HeartCore offers “Go IPO,” a consulting service where it assists private companies with uplisting onto the Nasdaq Stock Market. Additional information about the Company's products and services is available at www.heartcore.co.jp and https://heartcore-enterprises.com/.

Forward-Looking Statements
All statements other than statements of historical facts included in this press release are forward- looking statements. In some cases, forward-looking statements can be identified by words such as “believe,” “intend,” “expect,” “anticipate,” “plan,” “potential,” “continue” or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks, and uncertainties are discussed in HeartCore’s filings with the Securities and Exchange Commission. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond HeartCore’s control which could, and likely will materially affect actual results, and levels of activity, performance, or achievements. Any forward-looking statement reflects HeartCore’s current views with respect to future events and is subject to these and other risks, uncertainties, and assumptions relating to operations, results of operations, growth strategy, and liquidity. HeartCore assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The contents of any website referenced in this press release are not incorporated by reference herein.

HeartCore Investor Relations Contact:
Gateway Group, Inc.
Matt Glover and John Yi
HTCR@gatewayir.com
(949) 574-3860

 
HeartCore Enterprises, Inc.
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)
      
      
  For the three months
ended March 31,
  For the three months
ended March 31,
  2023   2022 
      
Revenues$8,734,150  $2,276,001 
Cost of revenues 3,101,066   1,055,356 
Gross profit 5,633,084   1,220,645 
      
Operating expenses:     
Selling expenses 568,642   205,918 
General and administrative expenses 2,685,207   2,468,933 
Research and development expenses 79,624   108,259 
Total operating expenses 3,333,473   2,783,110 
      
Income (loss) from operations 2,299,611   (1,562,465)
      
Other income (expenses):     
Changes in fair value of investments in warrants 193,365   - 
Interest income 31,605   1,458 
Interest expenses (39,840)  (11,271)
Other income 14,201   16,673 
Other expenses (29,457)  (23,662)
Total other income (expenses) 169,874   (16,802)
      
Income (loss) before income tax provision 2,469,485   (1,579,267)
      
Income tax expense (benefit) 661,448   (816)
      
Net income (loss) 1,808,037   (1,578,451)
Less: net loss attributable to non-controlling interest (74,252)  - 
Net income (loss) attributable to HeartCore Enterprises, Inc.$1,882,289  $(1,578,451)
      
Other comprehensive income (loss):     
Foreign currency translation adjustment (25,034)  80,053 
      
Total comprehensive income (loss) 1,783,003   (1,498,398)
Less: comprehensive loss attributable to non-controlling interest (76,542)  - 
Comprehensive income (loss) attributable to HeartCore Enterprises, Inc.$1,859,545  $(1,498,398)
      
Net income (loss) per common share attributable to HeartCore Enterprises, Inc.   
    Basic$0.10  $(0.09)
    Diluted$0.10  $(0.09)
      
Weighted average common shares outstanding     
    Basic 19,066,160   17,265,332 
    Diluted 19,066,160   17,265,332 
      
      


     
HeartCore Enterprises, Inc.
Condensed Consolidated Balance Sheets
     
  March 31, December 31,
  2023  2022 
  (Unaudited)  
ASSETS
     
Current assets:    
Cash and cash equivalents$5,209,915 $7,177,326 
Accounts receivable 2,380,128  551,064 
Short-term investment in warrants 437,812  - 
Prepaid expenses 919,916  538,230 
Due from related party 47,536  48,447 
Other current assets 31,534  220,070 
Total current assets 9,026,841  8,535,137 
     
Non-current assets:    
Property and equipment, net 214,566  203,627 
Operating lease right-of-use assets 2,549,834  2,644,957 
Intangible asset, net 4,993,750  - 
Goodwill 3,276,441  - 
Long-term investment in warrants 3,764,888  - 
Deferred tax assets 245,997  263,339 
Security deposits 367,981  244,395 
Long-term loan receivable from related party 229,955  246,472 
Other non-current assets 75  661 
Total non-current assets 15,643,487  3,603,451 
     
Total assets$24,670,328 $12,138,588 
     
LIABILITIES AND SHAREHOLDERS' EQUITY
     
Current liabilities:    
Accounts payable and accrued expenses$1,160,309 $497,742 
Accrued payroll and other employee costs 416,779  360,222 
Due to related party 2,923  402 
Current portion of long-term debts 640,534  697,877 
Insurance premium financing 352,518  - 
Factoring liability 173,582  - 
Operating lease liabilities, current 288,081  291,863 
Finance lease liabilities, current 13,663  19,294 
Income tax payables 681,830  2,747 
Deferred revenue 1,530,472  1,724,519 
Other current liabilities 225,167  53,027 
Total current liabilities 5,485,858  3,647,693 
     
Non-current liabilities:    
Long term debts 1,490,664  1,123,735 
Operating lease liabilities, non-current 2,314,160  2,421,054 
Finance lease liabilities, non-current -  459 
Deferred tax liabilities 1,398,250  - 
Other non-current liabilities 135,536  138,018 
Total non-current liabilities 5,338,610  3,683,266 
     
Total liabilities 10,824,468  7,330,959 
     
Shareholders' equity:    
Preferred shares ($0.0001 par value, 20,000,000 shares authorized, no shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively) -  - 
Common shares ($0.0001 par value, 200,000,000 shares authorized; 20,842,690 and 17,649,886 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively) 2,083  1,764 
Additional paid-in capital 19,079,516  15,014,607 
Accumulated deficit (8,691,290) (10,573,579)
Accumulated other comprehensive income 342,093  364,837 
Total HeartCore Enterprises, Inc. shareholders' equity 10,732,402  4,807,629 
Non-controlling interest 3,113,458  - 
Total shareholders' equity 13,845,860  4,807,629 
     
Total liabilities and shareholders' equity$24,670,328 $12,138,588 
     
     


 
HeartCore Enterprises, Inc.
Unaudited Condensed Consolidated Statements of Cash Flows
     
  For the three months ended March 31, For the three months ended March 31,
  2023  2022 
     
Cash flows from operating activities    
Net income (loss)$1,808,037 $(1,578,451)
Adjustments to reconcile net income (loss) to net cash     
used in operating activities:    
Depreciation and amortization expenses 123,312  24,889 
Amortization of debt issuance costs 758  866 
Non-cash lease expense 76,017  75,986 
Deferred income taxes (17,284) 6,311 
Stock-based compensation 915,228  422,164 
Warrants received as noncash consideration (4,009,335) - 
Changes in fair value of investments in warrants (193,365) - 
Changes in assets and liabilities:    
Accounts receivable (66,833) (217,638)
Prepaid expenses (45) (488,970)
Other assets 78,241  (34,896)
Accounts payable and accrued expenses (94,363) (79,982)
Accrued payroll and other employee costs (178,733) (27,492)
Due to related party 2,544  - 
Operating lease liabilities (73,147) (78,226)
Finance lease liabilities (53) (174)
Income tax payables 678,725  (10,037)
Deferred revenue (167,873) (295,176)
Other liabilities 70,110  (113,027)
Net cash flows used in operating activities (1,048,059) (2,393,853)
     
Cash flows from investing activities    
Purchases of property and equipment (9,409) (18,903)
Advance and loan provided to related party -  (25,480)
Repayment of loan provided to related party 11,955  9,102 
Payment for acquisition of subsidiary, net of cash acquired (724,910) - 
Net cash flows used in investing activities (722,364) (35,281)
     
Cash flows from financing activities    
Proceeds from initial public offering, net of issuance cost -  13,602,554 
Proceeds from issuance of common shares prior to initial public offering -  220,572 
Payments for finance leases (5,658) (14,916)
Proceeds from long-term debt -  258,087 
Repayment of long-term debts (265,255) (308,121)
Repayment of insurance premium financing (36,517) (41,280)
Repayment to related party -  (903)
Net proceeds from factoring arrangement 173,582  - 
Payments for debt issuance costs (448) (1,030)
Payment for mandatorily redeemable financial interest -  (430,489)
Net cash flows provided by (used in) financing activities (134,296) 13,284,474 
     
Effect of exchange rate changes (62,692) (78,293)
     
Net change in cash and cash equivalents (1,967,411) 10,777,047 
     
Cash and cash equivalents - beginning of the period 7,177,326  3,136,839 
     
Cash and cash equivalents - end of the period$5,209,915 $13,913,886 
     
Supplemental cash flow disclosures:    
Interest paid$16,968 $13,262 
Income taxes paid$- $1,489 
     
Non-cash investing and financing transactions    
Payroll withheld as repayment of loan receivable from employees$- $2,065 
Expense paid by related party on behalf of the Company$- $25,480 
Share repurchase liability settled by issuance of common shares$- $16 
Deferred offering costs recognized against the proceeds from the offering$- $178,847 
Insurance premium financing$389,035 $388,538 
Liabilities assumed in connection with purchase of property and equipment$6,288 $- 
Common shares issued for acquisition of subsidiary$3,150,000 $-